Literature DB >> 2674499

Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer.

J Kang1, J Kambayashi, M Sakon, T Tsujinaka, T Mori.   

Abstract

In order to elucidate the postoperative changes in hemostasis, three molecular markers; fibrinopeptide A (FPA), fibrinopeptide B beta 15-42 (B beta 15-42) and D-dimer, were serially determined in 27 gastric resections (group A), 27 hepatic resections (group B) and 4 probe laparotomies (group C). Unexpectedly, a postoperative hypercoagulable state was transient and of a low magnitude, as determined by the obtained value of FPA. On the other hand, a significant fibrinolysis (an elevation of B beta 15-42) was observed immediately after surgery which continued for over 10 days. The early phase of fibrinolysis, up until the 3rd postoperative day, is likely to be primary fibrinolysis, as it was not accompanied by the formation of D-dimer, which results from the digestion of fibrin by plasmin. The late phase, however, is considered to be secondary fibrinolysis, as D-dimer was elevated during this phase. Despite the different surgical procedures, these changes were basically similar between the patients who underwent gastric resections and those who underwent liver resections. The postoperative changes in hemostasis as presented herein may therefore be the general physiological response, at least against abdominal surgery.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674499     DOI: 10.1007/bf02471400

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  21 in total

1.  Studies on the release of plasminogen activator.

Authors:  F Markwardt; H P Klöcking
Journal:  Thromb Res       Date:  1976-02       Impact factor: 3.944

2.  Antigenic markers on fragment DD, a unique plasmic derivative of human crosslinked fibrin.

Authors:  A Z Budzynski; V J Marder; M E Parker; P Shames; B S Brizuela; S A Olexa
Journal:  Blood       Date:  1979-10       Impact factor: 22.113

3.  alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy.

Authors:  D Collen; M Verstraete
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

4.  Alteration in fibrinolysis associated with surgery and venous thrombosis.

Authors:  A O Mansfield
Journal:  Br J Surg       Date:  1972-10       Impact factor: 6.939

5.  Measurement in human blood of fibrinogen/fibrin fragments containing the B beta 15-42 sequence.

Authors:  B Kudryk; D Robinson; C Netré; B Hessel; M Blombäck; B Blombäck
Journal:  Thromb Res       Date:  1982-02-01       Impact factor: 3.944

6.  Inhibitors of kallikrein in human plasma.

Authors:  D J McConnell
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

7.  Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.

Authors:  D A Lane; H Ireland; S Wolff; R Grant; S Jennings; T Allen-Mersh
Journal:  Thromb Res       Date:  1982-04-15       Impact factor: 3.944

8.  Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices.

Authors:  J H Kang; J Kambayashi; M Sakon; H Shiozaki; Y Ogawa; T Ohshiro; T Mori
Journal:  Br J Surg       Date:  1987-01       Impact factor: 6.939

9.  Coagulation changes in elective surgery and trauma.

Authors:  A E Seyfer; A V Seaber; F A Dombrose; J R Urbaniak
Journal:  Ann Surg       Date:  1981-02       Impact factor: 12.969

10.  Measurement of fibrinopeptide A in human blood.

Authors:  H L Nossel; I Yudelman; R E Canfield; V P Butler; K Spanondis; G D Wilner; G D Qureshi
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  1 in total

1.  The possible risk of lower-limb sclerotherapy causing an extended hypercoagulable state.

Authors:  H Ariyoshi; J Kambayashi; S Tominaga; T Hatanaka
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.